Sachetta’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$57.2K Sell
994
-101
-9% -$5.8K 0.03% 186
2026
Q1
$66.4K Buy
1,095
+130
+13% +$7.58K 0.04% 173
2025
Q4
$52.1K Sell
965
-149
-13% -$7.17K 0.03% 196
2025
Q3
$50.2K Buy
1,114
+47
+4% +$2.19K 0.02% 263
2025
Q2
$49.4K Sell
1,067
-399
-27% -$19.6K 0.02% 256
2025
Q1
$89.4K Sell
1,466
-329
-18% -$19.2K 0.04% 201
2024
Q4
$102K Sell
1,795
-178
-9% -$9.95K 0.04% 198
2024
Q3
$102K Buy
1,973
+669
+51% +$31.4K 0.04% 202
2024
Q2
$64.4K Buy
1,304
+184
+16% +$8.23K 0.03% 232
2024
Q1
$57.5K Hold
1,120
0.03% 236
2023
Q4
$57.5K Buy
+1,120
New +$58.8K 0.03% 236

Other funds holding BMY

Sachetta's BMY Position: Q2 2026 in Review

Sachetta reduced its Bristol-Myers Squibb (BMY) stake by 9.2% in Q2 2026, selling an estimated $5.8K and leaving 994 shares worth $57.2K. The position accounts for 0.03% of the portfolio, ranked #186.

Sachetta first reported a position in BMY in Q4 2023 and has held it in 11 quarters since. The position peaked at $102K in Q3 2024. 565 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Sachetta held 994 shares of Bristol-Myers Squibb worth $57.2K as of Q2 2026.
  • Sachetta sold 101 Bristol-Myers Squibb shares in Q2 2026, an estimated $5.8K.
  • Bristol-Myers Squibb made up 0.03% of Sachetta's portfolio in Q2 2026, its #186 holding.
  • Sachetta first reported a position in Bristol-Myers Squibb in Q4 2023 and has held it in 11 quarters since.
  • Sachetta's Bristol-Myers Squibb position peaked at $102K in Q3 2024.
  • 565 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Sachetta's 13F filing for Q2 2026, filed 15 Jul 2026.